Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.

"COMPETING INTERESTS Dr. Højen has received speaking fees from MSD and speaking and consulting fees from Bayer and Bristol‐Myers Squibb/Phizer. Prof Larsen has served as an investigator for Janssen Scientific Affairs, LLC and Boehringer Ingelheim and received speaking and consulting fees from Bayer, Bristol‐Myers Squibb/Pfizer, Boehringer Ingelheim, MSD and AstraZeneca. Dr. Nilsen has received speaking fees from Boehringer Ingelheim and BMS/Pfizer; consulting fees from Bayer and Daiichi‐Sankyo; and grant support from BMS/Pfizer and Daiichi‐Sankyo. Prof. Lip reports consultancy and speaker fees from BMS/Pfizer, Boehringer Ingelheim and Daiichi‐Sankyo. Dr. Søgaard has received consulting fees from Bayer. The other authors declare no conflicts of interest."